BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24507936)

  • 1. Thrombospondin-2 overexpression in the skin of transgenic mice reduces the susceptibility to chemically induced multistep skin carcinogenesis.
    Kunstfeld R; Hawighorst T; Streit M; Hong YK; Nguyen L; Brown LF; Detmar M
    J Dermatol Sci; 2014 May; 74(2):106-15. PubMed ID: 24507936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism.
    Hawighorst T; Velasco P; Streit M; Hong YK; Kyriakides TR; Brown LF; Bornstein P; Detmar M
    EMBO J; 2001 Jun; 20(11):2631-40. PubMed ID: 11387198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice.
    Hawighorst T; Oura H; Streit M; Janes L; Nguyen L; Brown LF; Oliver G; Jackson DG; Detmar M
    Oncogene; 2002 Nov; 21(52):7945-56. PubMed ID: 12439745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
    Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
    J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis.
    Alitalo AK; Proulx ST; Karaman S; Aebischer D; Martino S; Jost M; Schneider N; Bry M; Detmar M
    Cancer Res; 2013 Jul; 73(14):4212-21. PubMed ID: 23695550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.
    Streit M; Riccardi L; Velasco P; Brown LF; Hawighorst T; Bornstein P; Detmar M
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14888-93. PubMed ID: 10611308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas.
    Streit M; Velasco P; Brown LF; Skobe M; Richard L; Riccardi L; Lawler J; Detmar M
    Am J Pathol; 1999 Aug; 155(2):441-52. PubMed ID: 10433937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultraviolet B-induced skin angiogenesis is associated with a switch in the balance of vascular endothelial growth factor and thrombospondin-1 expression.
    Yano K; Kajiya K; Ishiwata M; Hong YK; Miyakawa T; Detmar M
    J Invest Dermatol; 2004 Jan; 122(1):201-8. PubMed ID: 14962109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53.
    Page A; Navarro M; Suarez-Cabrera C; Alameda JP; Casanova ML; Paramio JM; Bravo A; Ramirez A
    Oncotarget; 2016 Apr; 7(15):20902-18. PubMed ID: 26959115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2--deficient mice.
    Lange-Asschenfeldt B; Weninger W; Velasco P; Kyriakides TR; von Andrian UH; Bornstein P; Detmar M
    Blood; 2002 Jan; 99(2):538-45. PubMed ID: 11781236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
    Koch M; Hussein F; Woeste A; Gründker C; Frontzek K; Emons G; Hawighorst T
    Breast Cancer Res Treat; 2011 Jul; 128(2):337-46. PubMed ID: 20714802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proangiogenic Properties of Thrombospondin-4.
    Muppala S; Frolova E; Xiao R; Krukovets I; Yoon S; Hoppe G; Vasanji A; Plow E; Stenina-Adognravi O
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):1975-86. PubMed ID: 26139464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damage.
    Yano K; Oura H; Detmar M
    J Invest Dermatol; 2002 May; 118(5):800-5. PubMed ID: 11982756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of thrombospondin-1 increases angiogenesis in a model of chronic inflammatory bowel disease.
    Zak S; Treven J; Nash N; Gutierrez LS
    Int J Colorectal Dis; 2008 Mar; 23(3):297-304. PubMed ID: 18043928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
    Go C; Li P; Wang XJ
    Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis.
    Hoesl C; Fröhlich T; Hundt JE; Kneitz H; Goebeler M; Wolf R; Schneider MR; Dahlhoff M
    Mol Oncol; 2019 Nov; 13(11):2476-2492. PubMed ID: 31580518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondins as anti-angiogenic therapeutic agents.
    Vailhé B; Feige JJ
    Curr Pharm Des; 2003; 9(7):583-8. PubMed ID: 12570805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1.
    Yano K; Kadoya K; Kajiya K; Hong YK; Detmar M
    Br J Dermatol; 2005 Jan; 152(1):115-21. PubMed ID: 15656811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice.
    Viarisio D; Mueller-Decker K; Kloz U; Aengeneyndt B; Kopp-Schneider A; Gröne HJ; Gheit T; Flechtenmacher C; Gissmann L; Tommasino M
    PLoS Pathog; 2011 Jul; 7(7):e1002125. PubMed ID: 21779166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein receptor-related protein contributes to the antiangiogenic activity of thrombospondin-2 in a murine glioma model.
    Fears CY; Grammer JR; Stewart JE; Annis DS; Mosher DF; Bornstein P; Gladson CL
    Cancer Res; 2005 Oct; 65(20):9338-46. PubMed ID: 16230396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.